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Retinitis pigmentosa is associated 
with shifts in the gut microbiome
Oksana Kutsyr1,3, Lucía Maestre‑Carballa1,3, Mónica Lluesma‑Gomez1, 
Manuel Martinez‑Garcia1*, Nicolás Cuenca1,2 & Pedro Lax1* 
The gut microbiome is known to influence the pathogenesis and progression of neurodegenerative 
diseases. However, there has been relatively little focus upon the implications of the gut microbiome 
in retinal diseases such as retinitis pigmentosa (RP). Here, we investigated changes in gut microbiome 
composition linked to RP, by assessing both retinal degeneration and gut microbiome in the rd10 
mouse model of RP as compared to control C57BL/6J mice. In rd10 mice, retinal responsiveness 
to flashlight stimuli and visual acuity were deteriorated with respect to observed in age‑matched 
control mice. This functional decline in dystrophic animals was accompanied by photoreceptor loss, 
morphologic anomalies in photoreceptor cells and retinal reactive gliosis. Furthermore, 16S rRNA 
gene amplicon sequencing data showed a microbial gut dysbiosis with differences in alpha and beta 
diversity at the genera, species and amplicon sequence variants (ASV) levels between dystrophic 
and control mice. Remarkably, four fairly common ASV in healthy gut microbiome belonging to 
Rikenella spp., Muribaculaceace spp., Prevotellaceae UCG‑001 spp., and Bacilli spp. were absent in 
the gut microbiome of retinal disease mice, while Bacteroides caecimuris was significantly enriched in 
mice with RP. The results indicate that retinal degenerative changes in RP are linked to relevant gut 
microbiome changes. The findings suggest that microbiome shifting could be considered as potential 
biomarker and therapeutic target for retinal degenerative diseases.
Neuronal degeneration is an intricate process in which intrinsic and environmental stress can affect vulnerable 
neurons to promote disease. Mounting evidence highlights the importance of a bidirectional crosstalk between 
the gastrointestinal bacteria and the central nervous  system1–3, and the impact of gut microbiome on brain and 
behavior is being extensively reported in the  literature4–8. The homeostasis of the gut microbiome is critical for 
maintaining human health, and imbalances in the microbial composition of the gut profoundly influences critical 
features of host physiology, including the development of metabolic disorders such as diabetes and  obesity7,9. 
Emerging data support the potential role for the gut microbiome in modulating many aspects of the brain 
function and behavior, with effects on the stress response, mood and anxiety disorders, motor activity, social 
interaction and memory, among  others10–15.
The interplay between the brain and the gut bacteria is mainly mediated by neural and immune networks, 
with crosstalk interactions between both  systems3,16. Thereby, the microbiome–gut–brain signaling system 
influences key brain processes, including neurogenesis, neurotransmission, neuroinflammation and neuronal 
 degeneration17–20. In this context, experimental data has proved that intestinal microbiome influences brain 
response to  injury21–23, and vice  versa24, so that changes in gut microbiome may affect recovery and treatment 
following brain  damage24. Besides, dysbiosis of the human gut microbiome has been associated with neurodegen-
erative disorders of the central nervous system that include Parkinson’s, Alzheimer’s and Huntington’s  disease25–29.
The retina has been historically considered a window to the brain, and anatomically the retina can be regarded 
as an extension of the central nervous system The structural and functional features of the retina make this 
tissue highly vulnerable to stressors, and homeostasis alterations significantly influence the progress of retinal 
 pathologies30. Moreover, the retina reflects some of the pathological alterations of many neurodegenerative 
diseases and may provide information of brain pathology  severity31,32. In this context, a few recent studies 
have linked gut microbiome changes with some retinal degenerative  diseases33,34, including age-related macular 
degeneration (AMD)35–39,  glaucoma40–43 and diabetic  retinopathy44, even though the published results vary 
depending on the type and stage of the disease and between studies. On the other hand, in a previous study we 
have demonstrated that invasive infection from gastrointestinal microbiome can induce activation of retinal 
 microglia45, the primary resident immune cell of the retina.
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Retinitis pigmentosa (RP) is a heterogeneous group of inherited diseases that cause photoreceptor degen-
eration, eventually leading to complete  blindness30. The death of photoreceptors is accompanied by chronic 
microglial activation and neuroinflammatory  processes46–48, concomitant with an increase of reactive oxygen 
 species49–52. RP disease-causing mutations have been identified in more than 80 different  genes53. The rd10 mouse 
model of RP has a missense mutation in the phosphodiesterase 6b (Pde6b)  gene54,55, inducing rod photoreceptor 
degeneration, which leads to secondary cone photoreceptor  death30,56. Time courses of photoreceptor cell death 
and subsequent retinal degeneration in rd10 mice closely resembles the human disease  process30,57.
To date, there are no empirical studies in the literature analyzing the gut microbiome composition in retinitis 
pigmentosa. In this study we analyzed the gut microbiome in control and rd10 mice at postnatal day (P) 32, 
when dystrophic animals are expected to have suffered from extensive retinal degeneration. We assessed retinal 
degeneration by functional electroretinography (ERG) and morphological techniques, and we evaluated the 
gut microbiome by Illumina 16S rRNA gene amplicon sequencing. We have confirmed degenerative changes 
in neuronal and glial retinal cells and demonstrated alterations in gut microbiome populations of RP animals. 
These results reinforce the general concept of the interdependence of gut microbiome and the central nervous 
system homeostasis and suggest that gut microbiome could potentially constitute a therapeutic target for RP 
and other retinal degenerative diseases.
Results
Degenerative changes in retinitis pigmentosa mice. RP mice showed altered retinal function and 
morphology. ERG flash responses from rd10 mice were smaller than those obtained in C57BL/6J mice (Fig. 1a). 
In rd10 mice, maximum amplitudes observed for scotopic a- and b-waves were 12% and 34% (respectively) 
of the values obtained in C57BL/6J mice (Fig. 1b,c). Also, visual acuity showed visual thresholds significantly 
smaller in rd10 mice (50% less) than those obtained in control mice (Fig. 1d). On the other hand, the mean 
thickness of the ONL was smaller in rd10 than in control mice throughout the retina (Fig. 1e). On average, the 
ONL thickness in rd10 mice was 31% of the values obtained in C57BL/6J mice (18.6 ± 1.6 vs. 60.4 ± 2.0 µm). 
Cone photoreceptors in control mice showed a normal morphology with visible inner and outer segments and 
long axons, and normal pedicles (Fig. 1f). Conversely, in rd10 mice cones exhibited a degenerated morphology, 
with small size cones and an almost absent inner and outer segments (Fig. 1g). In these animals, cone axons were 
almost loss and pedicles came out from the cell bodies. Besides, rod outer segments of RP mice were shorter and 
more disorganized than those of control animals (Fig. 1f,g).
Photoreceptor death was associated to reactive gliosis in the retina of rd10 mice. In control mice, Iba1-positive 
microglial cells were scarce in the outer retina and exhibited morphological features typical of resting microglia 
(Fig. 1h). By contrast, rd10 mice showed evident changes in Iba1-positive cells, with higher number of positive 
cells than observed in C57BL/6J retinas, and abundant iba1-positive cells in the outer nuclear layer (Fig. 1i). 
Moreover, Iba1-positive cells in rd10 retinas showed a phenotype characteristic of reactive microglia (Fig. 1i). 
Immunoreactivity for glial fibrillary acidic protein (GFAP) also evidenced a reactive gliosis in rd10 retinas. In 
C57BL/6J retinas, GFAP immunoreactivity was present only in the inner margin of the retina, corresponding to 
astrocyte cells (Fig. 1j). By contrast, retinal GFAP immunoreactivity in rd10 was present not only in the inner 
margin of the retina but also throughout Müller cells (Fig. 1k), which points to the activation of macroglial cells.
General gut microbial composition features. DNA from 8 mice’s gut and stool (4 from C57BL/6J 
mice and 4 from rd10 mice) was extracted and the 16S rRNA marker gene was amplified with PCR using the 
primers 341F and 805R, and then sequenced with Illumina technology. Reads were quality-filtered, merged (see 
methods and Supplementary Table S1) and analyzed with QIIME2.202058. The denoiser tool Deblur, available 
in  QIIME258, was used to remove sequencing errors (57–66% sequences per sample, Supplementary Table S2). 
After quality control processing, as a mean,  ≈ 100,000 final joined reads were obtained for denoising analysis that 
delivered ≈ 38,000 reads for taxonomic classification and 16S rRNA gene data analysis (Supplementary Tables S1 
and S2). Regarding general taxonomic features (Supplementary Figure S1), in both healthy C57BL/6J mice and 
diseased rd10 mice, the phyla Bacteroidota and Firmicutes were predominant in the gut representing 96% of the 
relative microbial abundance, followed by Deferribacterota and Desulfobacterota (Fig. 2a). At the species level, 12 
were predominant in both mice groups and represented from 94.23 up to 97.91% of the relative abundance per 
sample (Fig. 2b). Lactobacillus spp. was the most abundant specie in both rd10 (≈ 53%) and C57BL/6J (≈ 38%) 
mice while an uncultured Muribaculaceae bacterium was placed the second most abundant specie (Fig. 2b). 
Other common bacterial species in the gut were also detected, such as Bacteroides spp. and Alistipes spp.
Altered gut microbiome: differences in alpha and beta diversity. Despite these similarities on gen-
eral microbial features, apparent alpha and beta diversity differences were found in the microbial gut composi-
tion between healthy and diseased mice. First, regarding richness of amplicon sequence variants (ASV), higher 
number of ASV were found for control mice group (n = 94 ± 2) compared to diseased rd10 mice (n = 86 ± 3) 
(p = 0.0017, Fig. 3). In addition, 49 unique ASV were only found in healthy mice (representing an accumula-
tive relative abundance of 26.7%) whereas 48 were only found in rd10 mice (17.6% of the relative abundance) 
(see details in Supplementary Table S3). Second, more alpha-diversity was obtained for C57BL/6J healthy con-
trol mice when measured with Pielou’s Evenness, Shannon’s Diversity and Faith’s Phylogenetic Diversity indices 
(Supplementary Figure S1 and Supplementary Table S4). Furthermore, the principal coordinate analysis (PCoA) 
for the beta-diversity at different taxonomic ranks from family to species (Fig.  4a) and ASV (Fig.  4b) levels 
showed that C57BL/6J control mice grouped together and separately from rd10 disease mice. Indeed, these 
beta-diversity differences based on unweighted UniFrac distance were statistically significant (PERMANOVA 
test, p = 0.03, Supplementary Table S4) at the ASV level (Fig. 4b) between control and disease mice using Jaccard 
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Figure 1.  Retinal changes in RP mice. (a) Scotopic ERG responses to 1 log cd s/m2 flashes from a normal 
C57BL/6J (left) and dystrophic rd10 (right) mouse. The amplitudes of both the a- and b-waves are represented. 
(b, c) Luminance-response curves for the a- (b) and b-(c) waves of C57BL/6J (circles) and rd10 mice (squares). 
(d) Configuration of the optomotor system (left, image created using BioRender; https:// biore nder. com/) and 
visual acuity thresholds for C57BL/6J and rd10 mice (right). (e) Mean outer nuclear layer thickness in C57BL/6J 
(circles) and rd10 (squares) mice, quantified in both the temporal and the nasal side of the retina. (f, g) Retinal 
sections showing the outer retina of a C57BL/6J (f) and rd10 (g) mouse immunolabeled against cone arrestin 
(cone cells, in green) and rhodopsin (Rho, rod cells, in red). Nuclei were stained with TO-PRO 3 (in blue). 
(h–k) Retinal sections from a C57BL/6J (h, j) and rd10 (i, k) mouse, immunolabeled against Iba1 (microglia, in 
green) or GFAP (activated macroglia, in red). The cell nuclei were stained with TO-PRO 3 (in blue). ANOVA, 
Bonferroni’s test: *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ON: optic nerve, OS: outer segments, ONL: 
outer nuclear layer, OPL: outer plexiform layer, INL: inner nuclear layer, IPL: inner plexiform layer, GCL: 
ganglion cell layer. Scale bars: (f, g), 20 µm; (h–k), 50 µm.
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(p = 0.03) and Bray-courtis (p = 0.027) distance indices (Supplementary Table S4). Remarkably, when analyzed 
those taxa significantly enriched in control and disease mice with  ANCOM59, which compares the relative abun-
dance of each taxon with all the remaining features of the same category, data showed that four species (Rikenella 
spp, Muribaculaceace spp., Prevotellaceae UCG-001 spp., and Bacilli spp.) commonly present up to nearly 1% 
in healthy gut microbiome were absent in rd10 disease mice (Fig. 5 and Supplementary Tables S3 and S5). On 
the other hand, Bacteroides caecimuris was significantly overrepresented in rd10 mice with an average relative 
abundance of 0.7% (Fig. 5 and Supplementary Tables S3 and S5), while lacking in healthy gut mice. Finally, no 
difference in microbial composition was found between female versus male mice from both analyzed healthy 
and disease groups (tested with PERMANOVA, p > 0.05, Supplementary Table S4).
Discussion
Previous studies have linked gut microbiome changes with retinal degenerative diseases. Here we demonstrate for 
the first time that degenerative changes in neuronal and glial retinal cells concur with shifts in gut microbiome 
composition in an animal model of retinitis pigmentosa. The reported deteriorations in retinal responsiveness 
and in photoreceptor cell number and morphology of rd10 mice agrees with that previously shown for these 
 animals51,52. Also, retinal reactive gliosis observed in the dystrophic animals are consistent with the increases in 
Figure 2.  Taxonomic analysis of the mouse gut microbiome. (a) Relative abundance (%) at Phylum level for 
C57BL/J6 and rd10 mice gut microbiota. Dominant phyla were Bacteroidota and Firmicutes in both groups. (b) 
Relative abundance (%) of the most abundant species found in C57BL/6J and rd10 samples. Only species which 
had at least 1% of relative abundance in one of the samples were represented.
Figure 3.  Amplicon sequence variant analysis. Top panel: boxplot comparing the number of amplicon sequence 
variants (No. of ASV). One-way ANOVA test showed statistically significant differences between the number 
of ASV in healthy (red) and rd10 (blue) mice. First row of the table contains mean ± SD of ASV, the second one 
contains the number of unique ASV (not shared with the other group) for healthy (left) and rd10 mice (right). 
Graphic performed with the library ggboxplot available in R.
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microglial cell numbers and Müller cell reactivity described in previous  studies51,52, and point to the activation 
of pro-inflammatory pathways in these animals. In this context, previous results have demonstrated significant 
increases of inflammation markers in rd10  mice52, and augmented expression of proinflammatory cytokines has 
been previously reported by us in RP  animals48. The inflammatory state in retinitis pigmentosa animals persists 
throughout the life span even after photoreceptor  loss47, and concurs with significant increase of oxidative  stress52. 
In fact, it is assumed that apoptotic cell removal, inflammation and oxidative stress are common features in all 
retinal neurodegenerative diseases, including age-related macular degeneration, glaucoma, diabetic retinopathy 
and retinitis  pigmentosa30.
Initiation and progression of some prevalent retinal neurodegenerative diseases have also been linked to 
changes in the homeostasis of gut  microbiome33,34. In our results, sequencing analysis of the gut microbiome in 
dystrophic and control mice showed differences in alpha and beta diversity and interestingly, these differences 
were statistically supported at the ASV level. In recent reviews on best practices for analyzing  microbiomes60,61, 
ASV methods have been proposed as the reference metric to unveil differences in terms of microbial composition 
and have demonstrated sensitivity and specificity as good or better than previous methods and better discrimi-
nate ecological  patterns62–65. Remarkably, there were a large fraction of unique ASV present in only one of the 
Figure 4.  PCoA representation. (a) Principal coordinate analysis (PCoA) at species level, where C57BL/6J (red) 
and rd10 (blue) groups could be differentiated. (b) PCoA representing unweighted UniFrac distance for C57/6J 
(red) and rd10 (blue) mice gut were the two groups are separated from each other. The PERMANOVA test 
performed showed significant differences between the two groups.
Figure 5.  Heatmap that shows species that were identified by ANCOM as more abundant. Bacteroides 
caecimuris was more abundant in rd10 mice, while Prevotellaceae UCG-001 spp., Rikenella spp., Muribaculaceae 
spp. and Bacilli spp. were more frequent in C57BL/6J (C57) compared with the other mice group.
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groups (diseased or healthy), which overall contribution in relative microbial abundance variates between 17.6% 
(diseased mice) and 26.6% (healthy mice). For instance, four ASV classified as Rikenella spp., Muribaculaceace 
spp., Prevotellaceae UCG-001 spp., and Bacilli spp. were common in healthy gut microbiome but absent in the 
gut microbiome of retinal disease mice. Oppositely, B. caecimuris, normally rare in healthy gut microbiome, was 
significantly abundant in diseased mice. Thus, data showed a taxonomic partitioning for several ASV in the gut 
microbiome of diseased and healthy gut microbiomes. Precisely, these striking differences in terms of presence 
vs. absence of these unique ASVs likely explain our results on ASV microbial composition (Fig. 3) based on 
unweighted beta-diversity model (i.e. low and high abundant ASV have the same importance)66. When analyzing 
the data based on weighted beta diversity metric, which takes into account the relative abundance of all ASVs, 
differences were not statistically significant between diseased and healthy mice. This might be explained because 
with weighted beta diversity model, the relative contribution of most predominant species and ASVs, such as 
Lactobacillus and other abundant species described in Fig. 2b, likely mask the overall contributions of those less 
abundant species/ASV, which individually have a minor contribution with a relative abundance between 0.06 
and 6.85% each one depending on the group, despite there were contrasting differences in absence or presence 
for several ASV taxa (Fig. 5). Those unique low abundant ASV representing different rare bacterial taxa could be 
important in the gut’s ecosystem since it has been proved that rare or low frequent bacteria have key roles driving 
 ecosystems67, for instance, determining the bacterial gut composition in termite after different diet  variations68.
It has been reported that genera Rikenella and Prevotella were prevalent in 101 healthy mice gut microbiomes 
(including the C57BL/6J strain), being identified in 73.3% and 79.2% of the analyzed samples, thus being consid-
ered part of the healthy core of mice  gut69. In addition, bacteria belonging to the family Muribaculaceae are related 
to colonic inner mucus layer formation and barrier  function70, and the abundance of Muribaculaceae correlates 
with increased production of short-chain fatty acids and enhanced longevity in  mice71. Besides, it has been dem-
onstrated that relative abundance of Muribaculaceae negatively correlates with inflammatory  mediators70,72, and 
that fecal short-chain fatty acids concentrations are significantly reduced in Parkinson disease patients compared 
to  controls73. On the other hand, the abundance of Prevotellaceae has been reported to be reduced in feces of 
patients with neurological and psychiatric  disorders16, including multiple  sclerosis74, Parkinson  disease25,73 or 
major depressive  disorder75. Furthermore, previous studies have proved that the presence in gut microbiome of 
Bacilli spp., as Lactobacillus, can contribute to the production of short-chain fatty acids and collaborate in the 
maintenance of immune cells and the production anti-inflammatory  response76,77. Therefore, we can infer that 
the decline in the population density of these bacterial species may be related to the inflammatory and degen-
erative processes in RP mice.
Several different mechanisms have been proposed to explain how changes in the gut microbiome are linked 
to ocular  diseases34. Microbial imbalance can result in disruptions of the intestinal permeability and the blood-
retinal  barrier43, thus allowing bacteria and their products to induce ocular cells to an inflammatory  state34,35. 
Moreover, it has been hypothesized that gut dysbiosis may be a cause of increased levels of oxidative stress in 
the central nervous  system78. But also vice versa, central nervous system injuries may cause changes in the 
gut environment, and trigger alterations of gut  microbiome79. In this context, it has been demonstrated that 
brain injury may induce changes in the gut microbiome composition via altered autonomic  balance24. All these 
hypotheses are in concordance with the context of neuroinflammation, oxidative stress and cell death observed 
in RP mice. The link between gut microbiome composition and retinal health suggests that different stages of 
retinal degeneration might correspond to different gut microbiome changes. In this context, it has been demon-
strated that human pharyngeal microbiome varies depending on the stage of the disease in age-related macular 
 degeneration80. On the other hand, in our opinion, the restoration of the gut microbiome could prevent or reverse 
retinal degeneration. Previous studies have demonstrated that modification of the gut microbiota by microbiota 
 transplantation81, or by changing the  diet36, can attenuate the development of age-related macular degeneration, 
and that restructuring of the gut microbiome by intermittent fasting prevents retinopathy in diabetic  mice82.
Conclusions
Our results confirm previously described alterations in the morphology and function of the rd10 mouse, an 
animal model of retinitis pigmentosa, and demonstrate for the first time that retinal degenerative changes in 
neuronal and glial cells occurring in retinitis pigmentosa are concomitant with relevant gut microbiome changes. 
The findings could be extrapolated to patients suffering from retinitis pigmentosa or other ocular degenerative 
diseases and suggest that microbiome shifting could be considered as potential biomarker and therapeutic target 
for human retinal degenerative diseases. We realize that our results are preliminary and hope that it will lead and 
trigger further studies to elucidate the specificity of the interactions between the gut microbiome and retinitis 
pigmentosa or other retinal diseases. Continued investigations of the gut-retina axis could reveal unknown 
aspects of retinal diseases and potentially identify new relevant targets for therapeutic strategies.
Methods
Animals. Mice homozygous for the rd10 mutation (B6.CXBI-Pde6brd10/J) (n = 8) and wild-type C57BL/6J 
mice (Harlan Laboratories, Barcelona, Spain) (n = 8), half male, half female, were used in the study. Animals 
were maintained in cages under controlled temperature (23 ± 1  °C), humidity (60%) and photoperiod (12  h 
light/12 h dark, 50 lx). Water and food were provided ad libitum. At the end of the study, animals were humanely 
sacrificed by a lethal dose of sodium pentobarbital. The study has been approved by the Ethics Committee of the 
University of Alicante (UA-2018–07-06). All procedures were performed in conformity with current guidelines 
and regulations on the use of laboratory animals (European Directive 2010/63/EU, NIH, ARVO and ARRIVE) 
in an effort to reduce the number of animals used and limit unnecessary animal suffering.
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Electroretinographic records. In the morning of postnatal day 32, scotopic ERG responses were recorded 
bilaterally following previously reported  methodology52. After overnight dark adaptation, animals were anesthe-
tized under dim red light by intraperitoneal administration of 100 mg/kg of ketamine (Imalgene, Merial Labo-
ratorios S.A., Barcelona, Spain) and 4 mg/kg of xylazine (Xilagesic 2%, Laboratorios Calier, Barcelona, Spain), 
pupils were dilated with tropicamide 1% (Alcon Cusí, Barcelona, Spain), and the eyes were instilled with 0.2% 
polyacrylic acid carbomer (Novartis, Barcelona) to reduce dehydration and improve electrical connectivity with 
the recording electrodes (DTL fiber; Sauquoit Industries, Scranton, PA, USA). A reference needle electrode was 
placed in the head, under the scalp, and a ground electrode was placed in the mouth. During the recordings, 
into a Faraday cage, stable body temperature (37 ± 0.3 °C) and absolute darkness was maintained. Light stimuli 
(10-ms duration) were presented for at 11 logarithmically increasing luminance (from -5 to 1 log cd s/m2) by 
a Ganzfeld led stimulator. The responses to 3 to 10 consecutive stimuli were averaged for each light intensity. 
The spacing between flashes was 10 s for dim flashes (-5 to -0.8 log cd s/m2) and 20 s for bright flashes (0 to 1 
log cd s/m2). A data acquisition board (DAM50; World Precision Instruments, Aston, UK) was used to amplify 
and band-pass filter the signal (1–1000 Hz, without notch filtering). Stimuli administration and data acquisition 
(4 kHz) were accomplished using PowerLab-AD system (AD Instruments, Oxfordshire, UK).
Optomotor test. Visual acuity (VA) was assessed in C57BL/6J and rd10 mice, by evaluating optomotor 
responses in the Argos system (Instead, Elche, Spain). As described  previously52, spatial frequency thresholds 
were obtained by analyzing the response of the animals to vertically oriented drifting gratings (Fig. 1d). The 
initial spatial frequency tested was 0.088 cyc/deg and the temporal frequency was 0.8 Hz.
Tissue and stool collection. After ERG recording, animals were sacrificed, and tissue samples were col-
lected. For microbial analysis, colon and ileum segments were removed and stored at − 80 °C after quick immer-
sion in liquid nitrogen. For morphological analysis of the retinas, the eyes were enucleated after the placement of 
a suture to mark the dorsal margin of the limbus. The eyes were then fixed with 4% (w/v) paraformaldehyde for 
1 h at room temperature, washed with 0.1 M phosphate buffer (PB, pH 7.4) and cryoprotected through a series of 
increasing concentrations of sucrose (15, 20 and 30% (w/v)). Following, the cornea, lens and vitreous body were 
gently removed, the eyecups were embedded in Tissue-Tek OCT (Sakura Finetek, Zoeterwouden, Netherlands), 
frozen with liquid nitrogen and cut with a cryostat (CM 1900, Leica Microsystems, Wetzlar, Germany). Sections 
of thickness 16 μm were mounted on glass slides (Superfrost Plus; Menzel GmbH and Co. KG, Braunschweig, 
Germany) and stored at − 20 °C.
DNA extraction. For the microbiome study, 8 tissue and stool samples were used. Half of them were rd10 
and the other half were C57BL/6J, also there were 2 males and 2 females in each group. DNA was extracted 
from the samples using DNAeasy PowerSoil Pro (QIAGEN, Germany) according to the manufacturer’s protocol, 
including an extra sample incubation with CD2 at 4 °C during 5 min before being centrifuged. All centrifugations 
were carried at 15,100 G, minus the one used for removing the residual solution C5, centrifuged at 16,100 G.
PCR and sequencing of 16S rRNA gene amplicons. DNA from fecal and colon samples was subjected 
to amplification of polymerase chain reaction (PCR) using Pro341F (5-’TCG TCG GCA GCG TCA GAT GTG TAT 
AAG AGA CAG CCT ACGGGNBGCASCAG3′) and Pro805R (5′GTC TCG TGG GCT CGG AGA TGT GTA TAA 
GAG ACA GGA CTACNVGGG TAT CTA ATC -3′), targeting the V3-V4 region of 16S rRNA gene. The PCR condi-
tions were: 94 °C for 3 min, 25 cycles of 94 °C for 45 s, 51 °C for 1 min and 72 °C for 10 min. This was followed by 
72 °C for 10 min. PCR amplicons were cleaned and indexed as indicated in the Illumina’s MiSeq 16S Sequencing 
Library Protocol and sequenced with Miseq (2 × 300 pb). Sequencing was performed at the Genomics Center 
(FISABIO, Valencia, Spain).
Microbiome analysis. The sequenced data was quality filtered using prinseq-lite83, eliminating 0.89% of 
the reads, with the following parameters min_length: 50, trim_qual_right: 30, trim_qual_type: mean, trim_
qual_window: 20 and then joined with  FLASH84, using default parameters producing 814,069 amplicons (Sup-
plementary Table S1). The primers were removed with  cutadapt85, and the cleaned merged reads were analyzed 
with QIIME2.202058. Low quality reads were eliminated with quality-filter q-score, eliminating ≈54 merged 
reads/ sample. Deblur was used to trim the sequences at position 417 to remove low quality  regions86.
Diversity was studied using the QIIME2 plugin q2-diversity for C57BL/6J-rd10 mice and male–female  mice58. 
Specifically, alpha-diversity was evaluated with Pielou’s Evenness, Shannon’s Diversity index and Faith’s Phylo-
genetic Diversity index and compared with the no-parametric Kruskal–Wallis test. Beta-diversity was studied 
using PERMANOVA with the Bray-Courtis distance, Jaccard distance and weighted UniFrac and unweighted 
UniFrac distances. PCoAs (-p-metric seuclidean) were performed for representing beta-diversity and for all the 
taxonomic levels, that were previously collapsed. Taxonomy was assigned with the already pre-formatted SILVA 
138 database (reproducible sequence taxonomy reference database management for the masses)87. The compari-
son between taxa’s relative abundance to find differentially abundant features was performed with  ANCOM59. 
Accumulative relative abundance for unique ASV (present in C57BL/6J or rd10 mice, never both) was calculated 
adding the relative abundance of each unique ASV.
Immunohistochemistry. Immunohistochemical assessment of the retinas was achieved following previ-
ously reported  methodology52. Briefly, retinal sections were thawed at room temperature, washed 3 times with 
PB and incubated for 1  h in 0.1  M  PB with 10% (v/v) normal donkey serum and 0.5% Triton X-100. After 
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that, sections were immunolabeled overnight at 4 °C under agitation using combinations of primary antibod-
ies at different dilutions in 0.1 M PB with 0.5% Triton X-100: mouse monoclonal anti-rhodopsin (MAB5356, 
Merk Millipore, Darmstadt, Germany, 1:100), rabbit polyclonal anti-cone arrestin (AB15282, Merk Millipore, 
1:200), rabbit polyclonal anti-ionized calcium-binding adapter molecule 1 (Iba1) (019-19741, Wako Chemicals, 
Richmond, VA, USA, 1:1000) and mouse monoclonal anti-glial fibrillary acidic protein (GFAP) (G3893, Sigma-
Aldrich, Steinheim, Germany, 1:500). For objective comparison, rd10 and C57BL/6J retinas were processed in 
parallel. The slides were washed and then incubated with a mixture of corresponding secondary antibodies at 
a dilution of 1:100 in PB with 0.5% Triton X-100: AlexaFluor 488-anti-rabbit and AlexaFluor 555-anti-mouse 
(Invitrogen, Carlsbad, CA, USA). When corresponded, the nuclei marker TO-PRO 3-iodide (Invitrogen) was 
added at a dilution of 1:1000. Images were acquired on a Leica TCS SP8 confocal laser-scanning microscope 
(Leica Microsystems, Wetzlar, Germany).
Measurement of retina outer nuclear layer thickness. In order to assess photoreceptor death in 
retinal degenerative conditions, the thickness of the outer nuclear layer (ONL) was quantified in at least two 
non-consecutive sections per retina stained with hematoxylin. Retinal sections included the optic nerve and the 
temporal and nasal ora serrata. As the progression of the degeneration is not uniform throughout the retina, the 
quantification was performed every 0.5 mm, at distances of 0, 0.5, 1.0, 1.5, 2.0 and 2.3 mm from the optic nerve 
toward the periphery.
Statistical analysis. A one-way ANOVA was performed to assess the effects of genotype (rd10 vs. 
C57BL/6J) on ERG amplitude and ONL thickness, using the IBM SPSS statistics 24 software package (SPSS Inc, 
Chicago, IL, USA). Post hoc pairwise comparisons were done with the Bonferroni’s test. To assess the effects of 
genotype on visual acuity, a Mann–Whitney U test was applied. Diversity parameters were statistically evaluated 
using different QIIME2 tools (https:// qiime2. org/): the nonparametric Kruskal–Wallis test was used to compare 
alpha-diversity whereas beta-diversity was studied using PERMANOVA. The comparison between taxa’s rela-
tive abundance was performed with  ANCOM59, which found features that were more abundant in a group as 
compared with the other. One-way ANOVA was applied to study abundance differences between different taxon 
levels and ASV numbers using the R statistical software (4.0.2)88. A p value of less than 0.05 was considered to be 
statistically significant. All data were plotted as the average ± standard error of the mean.
Ethics declarations. All procedures were performed in conformity with current guidelines and regulations 
on the use of laboratory animals (European Directive 2010/63/EU, NIH and ARVO) in an effort to reduce the 
number of animals used and limit unnecessary animal suffering.
Approval for animal experiments. This study was approved by the Ethics Committee of the University 
of Alicante (UA-2018–07-06).
Data availability
The 16 s rRNA raw sequences generated during the current study were deposited at Sequence Read Archive 
(SRA) database which belongs to the National Center for Biotechnology Information. Bioproject number: 
PRJNA675447. Biosamples ID for C57BL/6J mice: SAMN16708365 (mouse 25), SAMN16708366 (mouse 26), 
SAMN16708367 (mouse 27) and SAMN16708368 (mouse 32). Biosamples ID for rd10 mice: SAMN16708371 
(mouse 88), SAMN16708372 (mouse 99), SAMN16708369 (mice 102) and SAMN16708370 (mouse109).
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